echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > A&R: The enhancement of interferon gene stimulating factor induces the production of type I interferon in COPA syndrome

    A&R: The enhancement of interferon gene stimulating factor induces the production of type I interferon in COPA syndrome

    • Last Update: 2021-12-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Oatomer subunit alpha (COPA) syndrome, also known as autoinflammatory interstitial lung, joint, and kidney disease, is caused by heterozygous mutations in COPA .
    The study found a new variant of COPA in 4 patients in a family .
    By studying these 4 patients and analyzing the results of the gene-targeted mouse model, we can clarify whether and how the mutation causes the symptoms of COPA syndrome .

    Oatomer subunit alpha (COPA) syndrome, also known as autoinflammatory interstitial lung, joint, and kidney disease, is caused by heterozygous mutations in COPA COPA .


    The study found a new variant of COPA in 4 patients in a family .
    By studying these 4 patients and analyzing the results of the gene-targeted mouse model, we can clarify whether and how the mutation causes the symptoms of COPA syndrome .

     

    The study .


    7 family members were all the exons of genomic sequencing peripheral blood mononuclear cells , and using RT-qPCR measured in peripheral blood cells of the I interferon (IFN) relevant mRNA expression (including ISG15 , IFIT1 , IFI44L , SIGLEC1 , IFI27 and RSAD2 )


    The study .
    7 family members were all the exons of genomic sequencing peripheral blood mononuclear cells , and using RT-qPCR measured in peripheral blood cells of the I interferon (IFN) relevant mRNA expression (including ISG15 ISG15 , , IFIT1 IFIT1 , , IFI44L IFI44L , , of a SIGLECl of a SIGLECl , , IFI27 IFI27 and RSAD2 RSAD2 )


    Researchers identified heterozygous mutations in COPA COPA ( c.
    725T>G , p.
    Val242Gly ) in 4 affected family members .
    Family members with this mutation have higher IFN scores .
    In vitro analysis showed that COPA COPA V242G and previously reported pathogenic mutations enhanced the type I IFN promoter activity induced by stimulus of interferon gene (STING) .
    Copa Copa V242G/+ V242G/+ mice exhibited interstitial lung disease and STING -dependent interferon-stimulated gene expression .


    V242G is a new type of COPA COPA mutation found in 4 patients in one family .
    Interstitial lung disease appeared in gene-targeted mice with the V242G mutation, and the response of the STING pathway was enhanced, leading to an increase in type I IFN production .
    By focusing on the activation of the STING pathway, a new treatment strategy for COPA syndrome was introduced .
    By focusing on the activation of the STING pathway, a new treatment strategy for COPA syndrome was introduced .
     

    Original source:

    Original source:

    Kato, T.


    , Yamamoto, M.
    , Honda, Y.
    , Orimo, T.
    (2021), Augmentation of Stimulator of Interferon Genes--Induced Type I Interferon Production in COPA Syndrome.
    Arthritis Rheumatol, 73: 2105-2115.


    Kato, T.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.